retatrutide trial results news A new clinical from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes retatrutide clinical trial stage Retatrutide

Not study volunteers

Print this page or save it as a PDF for quick reference at your workstation

Newer medications with longer half-lives, such as semaglutide ( Ozempic ), which can be administered once weekly, have improved patient adherence and convenience, which is boosting market adoption

A retrospective 2024 study evaluated nearly 700 subjects with type 2 diabetes who were taking a GLP-1 drug and found no association between GLP-1s and worsening retinopathy

Brussels, Belgium

Comparing GLP-1 Activators and GLP-1 Medications While medications like GLP-1 vs Ozempic can show rapid outcomes, they often stop working once discontinued